ID   CACB3_HUMAN             Reviewed;         484 AA.
AC   P54284; A8K0Z4; B7Z4Q1; B7Z973; B7ZAK8; F5GZW7; F5H2P6; F8VSG3; Q13913;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   07-APR-2021, entry version 196.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit beta-3;
DE            Short=CAB3;
DE   AltName: Full=Calcium channel voltage-dependent subunit beta 3;
GN   Name=CACNB3; Synonyms=CACNLB3 {ECO:0000303|PubMed:7557998};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Murakami M., Klugbauer N., Flockerzi V.;
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7557998; DOI=10.1006/geno.1995.1048;
RA   Yamada Y., Masuda K., Li Q., Ihara Y., Kubota A., Miura T., Nakamura K.,
RA   Fujii Y., Seino S., Seino Y.;
RT   "The structures of the human calcium channel alpha 1 subunit (CACNL1A2) and
RT   beta subunit (CACNLB3) genes.";
RL   Genomics 27:312-319(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RA   Furneaux H.M.;
RL   Submitted (FEB-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8119293; DOI=10.1111/j.1432-1033.1994.tb18621.x;
RA   Collin T., Lory P., Taviaux S., Courtieu C., Guilbault P., Berta P.,
RA   Nargeot J.;
RT   "Cloning, chromosomal location and functional expression of the human
RT   voltage-dependent calcium-channel beta 3 subunit.";
RL   Eur. J. Biochem. 220:257-262(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, Small intestine, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH CACNA2D4, AND IDENTIFICATION IN A COMPLEX WITH CACNA1C.
RX   PubMed=12181424; DOI=10.1124/mol.62.3.485;
RA   Qin N., Yagel S., Momplaisir M.-L., Codd E.E., D'Andrea M.R.;
RT   "Molecular cloning and characterization of the human voltage-gated calcium
RT   channel alpha(2)delta-4 subunit.";
RL   Mol. Pharmacol. 62:485-496(2002).
RN   [10]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [11]
RP   INTERACTION WITH CACNA1C, AND SUBUNIT.
RX   PubMed=29742403; DOI=10.1016/j.bpj.2018.03.029;
RA   Bartels P., Yu D., Huang H., Hu Z., Herzig S., Soong T.W.;
RT   "Alternative Splicing at N Terminus and Domain I Modulates CaV1.2
RT   Inactivation and Surface Expression.";
RL   Biophys. J. 114:2095-2106(2018).
CC   -!- FUNCTION: Regulatory subunit of the voltage-gated calcium channel that
CC       gives rise to L-type calcium currents (PubMed:8119293). Increases
CC       CACNA1B peak calcium current and shifts the voltage dependencies of
CC       channel activation and inactivation (By similarity). Increases CACNA1C
CC       peak calcium current and shifts the voltage dependencies of channel
CC       activation and inactivation (By similarity).
CC       {ECO:0000250|UniProtKB:P54287, ECO:0000250|UniProtKB:Q9MZL3,
CC       ECO:0000269|PubMed:8119293}.
CC   -!- SUBUNIT: Component of a calcium channel complex consisting of a pore-
CC       forming alpha subunit (CACNA1C) and the ancillary subunits CACNB3 and
CC       CACNA2D1 (PubMed:29742403). The channel complex contains alpha, beta,
CC       gamma and delta subunits in a 1:1:1:1 ratio (Probable). Interacts with
CC       CACNA2D4 (PubMed:12181424). Interacts with FASLG (PubMed:19807924).
CC       Interacts with CBARP; prevents the interaction of CACNB3 with the alpha
CC       subunit CACNA1C thereby negatively regulating the activity of the
CC       corresponding calcium channel (By similarity).
CC       {ECO:0000250|UniProtKB:P54287, ECO:0000269|PubMed:12181424,
CC       ECO:0000269|PubMed:19807924, ECO:0000269|PubMed:29742403, ECO:0000305}.
CC   -!- INTERACTION:
CC       P54284; Q9H1P6: C20orf85; NbExp=3; IntAct=EBI-1184651, EBI-12155483;
CC       P54284; Q13936: CACNA1C; NbExp=2; IntAct=EBI-1184651, EBI-1038838;
CC       P54284; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-1184651, EBI-742887;
CC       P54284; Q6FI81: CIAPIN1; NbExp=5; IntAct=EBI-1184651, EBI-750511;
CC       P54284; P56545-3: CTBP2; NbExp=8; IntAct=EBI-1184651, EBI-10171902;
CC       P54284; P55040: GEM; NbExp=8; IntAct=EBI-1184651, EBI-744104;
CC       P54284; P50221: MEOX1; NbExp=3; IntAct=EBI-1184651, EBI-2864512;
CC       P54284; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-1184651, EBI-11522433;
CC       P54284; Q15477: SKIV2L; NbExp=3; IntAct=EBI-1184651, EBI-373226;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P54285}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=3A;
CC         IsoId=P54284-1; Sequence=Displayed;
CC       Name=2; Synonyms=3B;
CC         IsoId=P54284-2; Sequence=VSP_000634;
CC       Name=3;
CC         IsoId=P54284-3; Sequence=VSP_046708;
CC       Name=4;
CC         IsoId=P54284-4; Sequence=VSP_046709;
CC       Name=5;
CC         IsoId=P54284-5; Sequence=VSP_046710;
CC   -!- TISSUE SPECIFICITY: Expressed mostly in brain, colon and ovary.
CC       {ECO:0000269|PubMed:8119293}.
CC   -!- SIMILARITY: Belongs to the calcium channel beta subunit family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X76555; CAA54055.1; -; mRNA.
DR   EMBL; X76556; CAA54056.1; -; mRNA.
DR   EMBL; D43704; BAA07803.1; -; Genomic_DNA.
DR   EMBL; U07139; AAA95958.1; -; mRNA.
DR   EMBL; L27584; AAA19799.1; -; mRNA.
DR   EMBL; AK289709; BAF82398.1; -; mRNA.
DR   EMBL; AK297639; BAH12637.1; -; mRNA.
DR   EMBL; AK304537; BAH14209.1; -; mRNA.
DR   EMBL; AK316323; BAH14694.1; -; mRNA.
DR   EMBL; AC117498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58008.1; -; Genomic_DNA.
DR   EMBL; BC041811; AAH41811.1; -; mRNA.
DR   CCDS; CCDS55821.1; -. [P54284-3]
DR   CCDS; CCDS55822.1; -. [P54284-4]
DR   CCDS; CCDS55823.1; -. [P54284-5]
DR   CCDS; CCDS8769.1; -. [P54284-1]
DR   PIR; S39315; S39315.
DR   PIR; S39316; S39316.
DR   PIR; S41211; S41211.
DR   RefSeq; NP_000716.2; NM_000725.3. [P54284-1]
DR   RefSeq; NP_001193844.1; NM_001206915.1. [P54284-5]
DR   RefSeq; NP_001193845.1; NM_001206916.1. [P54284-4]
DR   RefSeq; NP_001193846.1; NM_001206917.1. [P54284-3]
DR   SMR; P54284; -.
DR   BioGRID; 107238; 21.
DR   DIP; DIP-39138N; -.
DR   IntAct; P54284; 18.
DR   STRING; 9606.ENSP00000301050; -.
DR   BindingDB; P54284; -.
DR   ChEMBL; CHEMBL3430901; -.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB09231; Benidipine.
DR   DrugBank; DB13746; Bioallethrin.
DR   DrugBank; DB11148; Butamben.
DR   DrugBank; DB11093; Calcium citrate.
DR   DrugBank; DB11348; Calcium Phosphate.
DR   DrugBank; DB14481; Calcium phosphate dihydrate.
DR   DrugBank; DB09232; Cilnidipine.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00153; Ergocalciferol.
DR   DrugBank; DB13961; Fish oil.
DR   DrugBank; DB09236; Lacidipine.
DR   DrugBank; DB00825; Levomenthol.
DR   DrugBank; DB00653; Magnesium sulfate.
DR   DrugBank; DB09238; Manidipine.
DR   DrugBank; DB01388; Mibefradil.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00393; Nimodipine.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB00243; Ranolazine.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB09089; Trimebutine.
DR   TCDB; 8.A.22.1.3; the ca(2+) channel auxiliary subunit Beta types 1-4 (cca-Beta) family.
DR   iPTMnet; P54284; -.
DR   PhosphoSitePlus; P54284; -.
DR   BioMuta; CACNB3; -.
DR   DMDM; 1705683; -.
DR   jPOST; P54284; -.
DR   MassIVE; P54284; -.
DR   MaxQB; P54284; -.
DR   PaxDb; P54284; -.
DR   PeptideAtlas; P54284; -.
DR   PRIDE; P54284; -.
DR   ProteomicsDB; 25153; -.
DR   ProteomicsDB; 26032; -.
DR   ProteomicsDB; 28606; -.
DR   ProteomicsDB; 56673; -. [P54284-1]
DR   ProteomicsDB; 56674; -. [P54284-2]
DR   Antibodypedia; 13690; 210 antibodies.
DR   DNASU; 784; -.
DR   Ensembl; ENST00000301050; ENSP00000301050; ENSG00000167535. [P54284-1]
DR   Ensembl; ENST00000536187; ENSP00000444160; ENSG00000167535. [P54284-4]
DR   Ensembl; ENST00000540990; ENSP00000445495; ENSG00000167535. [P54284-3]
DR   Ensembl; ENST00000547230; ENSP00000448304; ENSG00000167535. [P54284-5]
DR   GeneID; 784; -.
DR   KEGG; hsa:784; -.
DR   UCSC; uc001rsl.3; human. [P54284-1]
DR   CTD; 784; -.
DR   DisGeNET; 784; -.
DR   GeneCards; CACNB3; -.
DR   HGNC; HGNC:1403; CACNB3.
DR   HPA; ENSG00000167535; Tissue enhanced (brain).
DR   MIM; 601958; gene.
DR   neXtProt; NX_P54284; -.
DR   OpenTargets; ENSG00000167535; -.
DR   PharmGKB; PA89; -.
DR   VEuPathDB; HostDB:ENSG00000167535.7; -.
DR   eggNOG; KOG3812; Eukaryota.
DR   GeneTree; ENSGT00950000182837; -.
DR   HOGENOM; CLU_021995_0_1_1; -.
DR   InParanoid; P54284; -.
DR   OMA; PCQGSAD; -.
DR   OrthoDB; 926074at2759; -.
DR   PhylomeDB; P54284; -.
DR   TreeFam; TF316195; -.
DR   PathwayCommons; P54284; -.
DR   Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-HSA-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   BioGRID-ORCS; 784; 202 hits in 988 CRISPR screens.
DR   ChiTaRS; CACNB3; human.
DR   GeneWiki; CACNB3; -.
DR   GenomeRNAi; 784; -.
DR   Pharos; P54284; Tbio.
DR   PRO; PR:P54284; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P54284; protein.
DR   Bgee; ENSG00000167535; Expressed in right frontal lobe and 209 other tissues.
DR   ExpressionAtlas; P54284; baseline and differential.
DR   Genevisible; P54284; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0005246; F:calcium channel regulator activity; ISS:UniProtKB.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc.
DR   GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; ISS:BHF-UCL.
DR   GO; GO:0090650; P:cellular response to oxygen-glucose deprivation; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0051899; P:membrane depolarization; TAS:Reactome.
DR   GO; GO:1905788; P:negative regulation of detection of mechanical stimulus involved in sensory perception of touch; IEA:Ensembl.
DR   GO; GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0007528; P:neuromuscular junction development; IBA:GO_Central.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:1901843; P:positive regulation of high voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:BHF-UCL.
DR   GO; GO:1902630; P:regulation of membrane hyperpolarization; IEA:Ensembl.
DR   GO; GO:0098903; P:regulation of membrane repolarization during action potential; ISS:BHF-UCL.
DR   GO; GO:1901385; P:regulation of voltage-gated calcium channel activity; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl.
DR   CDD; cd12042; SH3_CACNB3; 1.
DR   InterPro; IPR035760; CACNB3_SH3.
DR   InterPro; IPR008145; GK/Ca_channel_bsu.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008079; VDCC_L_b3su.
DR   InterPro; IPR000584; VDCC_L_bsu.
DR   Pfam; PF00625; Guanylate_kin; 1.
DR   Pfam; PF12052; VGCC_beta4Aa_N; 1.
DR   PRINTS; PR01626; LCACHANNELB.
DR   PRINTS; PR01696; LCACHANNELB3.
DR   SMART; SM00072; GuKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Cytoplasm; Ion channel; Ion transport; Phosphoprotein; Reference proteome;
KW   SH3 domain; Transport; Voltage-gated channel.
FT   CHAIN           1..484
FT                   /note="Voltage-dependent L-type calcium channel subunit
FT                   beta-3"
FT                   /id="PRO_0000144056"
FT   DOMAIN          59..128
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          195..345
FT                   /note="Mediates interaction with the alpha subunit"
FT                   /evidence="ECO:0000250|UniProtKB:P54287"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54287"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54287"
FT   VAR_SEQ         1..15
FT                   /note="MYDDSYVPGFEDSEA -> ME (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046708"
FT   VAR_SEQ         1..15
FT                   /note="MYDDSYVPGFEDSEA -> MSFSDSSATFLLNE (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046709"
FT   VAR_SEQ         57..97
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046710"
FT   VAR_SEQ         440..484
FT                   /note="HRQHTSGLPSANGHDPQDRLLAQDSEHNHSDRNWQRNRPWPKDSY -> QCQ
FT                   LLSLL (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_000634"
FT   VARIANT         423
FT                   /note="R -> H (in dbSNP:rs2229954)"
FT                   /id="VAR_024384"
FT   CONFLICT        7
FT                   /note="V -> L (in Ref. 4; AAA19799)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        32
FT                   /note="Missing (in Ref. 4; AAA19799)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        60
FT                   /note="V -> E (in Ref. 4; AAA19799)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        101
FT                   /note="N -> D (in Ref. 5; BAH14694)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="Q -> R (in Ref. 5; BAH14209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        196
FT                   /note="M -> T (in Ref. 5; BAH12637)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        245
FT                   /note="S -> P (in Ref. 5; BAH12637)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        320
FT                   /note="Missing (in Ref. 4; AAA19799)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="H -> L (in Ref. 4; AAA19799)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421
FT                   /note="S -> T (in Ref. 4; AAA19799)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   484 AA;  54532 MW;  19CD3549F5A8E17A CRC64;
     MYDDSYVPGF EDSEAGSADS YTSRPSLDSD VSLEEDRESA RREVESQAQQ QLERAKHKPV
     AFAVRTNVSY CGVLDEECPV QGSGVNFEAK DFLHIKEKYS NDWWIGRLVK EGGDIAFIPS
     PQRLESIRLK QEQKARRSGN PSSLSDIGNR RSPPPSLAKQ KQKQAEHVPP YDVVPSMRPV
     VLVGPSLKGY EVTDMMQKAL FDFLKHRFDG RISITRVTAD LSLAKRSVLN NPGKRTIIER
     SSARSSIAEV QSEIERIFEL AKSLQLVVLD ADTINHPAQL AKTSLAPIIV FVKVSSPKVL
     QRLIRSRGKS QMKHLTVQMM AYDKLVQCPP ESFDVILDEN QLEDACEHLA EYLEVYWRAT
     HHPAPGPGLL GPPSAIPGLQ NQQLLGERGE EHSPLERDSL MPSDEASESS RQAWTGSSQR
     SSRHLEEDYA DAYQDLYQPH RQHTSGLPSA NGHDPQDRLL AQDSEHNHSD RNWQRNRPWP
     KDSY
//
